Location History:
- Aichi, JA (1976)
- Aichi, JP (1981 - 1987)
Company Filing History:
Years Active: 1976-1987
Title: Mitsuaki Nagasaka: Innovator in Pharmaceutical Chemistry
Introduction
Mitsuaki Nagasaka is a prominent inventor based in Aichi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 6 patents, Nagasaka has focused on developing novel compounds that address various health issues.
Latest Patents
Nagasaka's latest patents include the development of ergoline derivatives and acid addition salts thereof. These novel ergoline derivatives exhibit excellent anti-hypertensive activity, vasodilating activity, anti-ulcer activity, gastric secretion inhibitory activity, brain metabolism improving activity, anti-depressive activity, and dopamine-like activity. As a result, they are useful for the prevention and treatment of various diseases such as hypertension, vein disorders, peptic ulcers, brain abnormalities, depression, Parkinson's disease, and high prolactin blood disease. Another significant patent involves certain pyridyloxy-or-thio-phenyl propenoic acid derivatives. These novel pyridine compounds and their pharmaceutically acceptable salts possess specific inhibitory activity on thromboxane A2 biosynthesis in mammals. They are beneficial for preventing and treating disorders caused by thromboxane A2, including thrombosis, cardiac infarction, diabetic vascular complications, and asthma.
Career Highlights
Throughout his career, Nagasaka has worked with notable companies such as Maruko Seiyaku Co., Ltd. and Taiho Pharmaceutical Company Limited. His work in these organizations has allowed him to further his research and development in pharmaceutical innovations.
Collaborations
Nagasaka has collaborated with esteemed colleagues, including Sachio Ohno and Kiyoshi Mizukoshi. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Mitsuaki Nagasaka is a distinguished inventor whose work in pharmaceutical chemistry has led to the creation of innovative compounds with significant therapeutic potential. His contributions continue to impact the field positively, addressing critical health challenges.